View allAll Photos Tagged Cancer
IAEA World Cancer Day Event at the Agency headquarters in Vienna, Austria. 3 February 2016.
Main Speakers:
Her Royal Highness Princess Dina Mired of Jordan
Her Excellency the First Lady of Belize Ms Kim Simplis Barrow
Mr Amadou Diarra of the International Federation of Pharmaceutical Manufacturers & Associations
Photo Credit: Dean Calma / IAEA
IAEA World Cancer Day Event at the Agency headquarters in Vienna, Austria. 3 February 2016.
Main Speakers:
Her Royal Highness Princess Dina Mired of Jordan
Her Excellency the First Lady of Belize Ms Kim Simplis Barrow
Mr Amadou Diarra of the International Federation of Pharmaceutical Manufacturers & Associations
Photo Credit: Dean Calma / IAEA
Ivy:....breast cancer awareness month.
Rosy: And that is why we are all in pink.
Holly: We may be all in pink but we still look very orangey since Lindamom does not use a flash.
Ivy: That is too bad because my beanbag chair is very pink.
Rosy: Isn't that Mr. Squishy you are sitting on?
Holly: Whatever color we are wearing we are still thinking about all the women who died from breast cancer and those who survived!
Ivy: I agree!
Rosy: I agree!
Me: Five years and five months survivor!
March 6, 2014: The GRU Cancer Center welcomed fellow oncologists to discover and discuss information from this year’s SABCS.
Presentations included:
Review of the San Antonio Breast Cancer Symposium presented by Shou-Ching Tang, MD, PhD, FACP, FRCPC
Formerly Professor of Medicine from the University of Minnesota, Martha Bacon Stimpson Endowed Chair in Medical Oncology and US Oncology National Scientific Advisor; Now at the GRU Cancer Center as Leader of the Breast Cancer Multidisciplinary Team
AACR Science of Cancer Health Disparities Conference Review: Disparities in Breast Cancer presented by Nita J. Maihle, PhD
Formerly Director of the Female Reproductive Tract Cancers Program at Yale University and Founding Director of the Tumor Biology Program at Mayo Clinic; Now at GRU Cancer Center as the new Cancer Center Associate Director for Education
This photo was taken after the biopsy. It's a bit hard to see where that was taken but I think the irregular raised area in the centre must be the remnants. Look how damaged the 'normal' skin looks!
March 6, 2014: The GRU Cancer Center welcomed fellow oncologists to discover and discuss information from this year’s SABCS.
Presentations included:
Review of the San Antonio Breast Cancer Symposium presented by Shou-Ching Tang, MD, PhD, FACP, FRCPC
Formerly Professor of Medicine from the University of Minnesota, Martha Bacon Stimpson Endowed Chair in Medical Oncology and US Oncology National Scientific Advisor; Now at the GRU Cancer Center as Leader of the Breast Cancer Multidisciplinary Team
AACR Science of Cancer Health Disparities Conference Review: Disparities in Breast Cancer presented by Nita J. Maihle, PhD
Formerly Director of the Female Reproductive Tract Cancers Program at Yale University and Founding Director of the Tumor Biology Program at Mayo Clinic; Now at GRU Cancer Center as the new Cancer Center Associate Director for Education
Entry in category 1. Object of study; Copyright CC-BY-NC-ND: Konstantin Bräutigam
This routine hematoxylin-eosin (HE) stained slide shows an aggressive pancreatic cancer formation infiltrating a small nerve. The malignant mucin-filled gland beleaguers the perineural sheath. Carcinoma cells show prominent nucleoli and heterogeneous contours. Adjacent to the perineural invasion is a small blood vessel which is (so far) not affected but in close proximity. Pancreatic cancer is still a fatal malignancy with a weak prognosis. Research and public awareness are mandatory.
81 year old woman with a 2 year history of rectal bleeding. Biopsy showed moderately differentiated adenocarcionma.
This inflatable colon was on display at Henry Ford Hospital as a part of Colorectal Cancer Awareness Month.
Colorectal cancer is the third most common cancer diagnosed in men and women in the U.S. Although the disease can affect anyone, more than 90% of diagnosed patients are over age 40.
ANSH Challenge 2/4
Four photos of anything that contains "CAN" in the word.
When I was diagnosed with breast cancer 3 years ago my grandmother bought me these three figurines. She knows how much I love dogs of all kinds and the ladybug in the middle has wings that open up to reveal a music box. Last year my grandmother herself was diagnosed with breast cancer, so these three figurines are very close to my heart.
October is Breast Cancer Awareness Month, and pink is the color used to show support for efforts to find a cure...Stand Proud and Keep Fighting!
KaTink (formerly PNP) has a vast variety of props, poses and backgrounds for all your SL photographic needs. Props, poses, photography, wedding poses, single poses, runway poses, action poses, couples poses. fantasy poses, backgrounds, backdrop, PNP,
KaTink - Poses and Photographic Artistry
maps.secondlife.com/secondlife/Phoenix%20Determined/69/15...
marketplace.secondlife.com/stores/65727
Pictures Taken by KaTink Creator & Photographer : Maliah Naidoo
A review of medical records of patients treated at an academic tertiary care center suggests that obese patients present to their physicians with more advanced stage and more aggressive forms of papillary thyroid cancer (PTC), according to a report published Online First by Archives of Surgery.
Thyroid cancer is on the rise on the United States and most of the increase is due to PTC, although the authors write that it is debatable whether the increase is caused by an enhanced risk of cancer or an increase in detection. Obesity is recognized as a risk factor for a variety of cancers, the authors provide as study background.
"Our study shows that those patients with increasing BMI have a progressively increasing risk in presenting with late-stage PTC. This finding is especially seen in the obese and morbidly obese populations," the researchers comment.
Avital Harari, M.D., and colleagues at the UCLA David Geffen School of Medicine, Los Angeles, reviewed the medical records of all patients older than 18 who underwent total thyroidectomy (removal of most or all of the thyroid gland) as an initial procedure for PTC or its variants from January 2004 through March 2011.
The final analysis included 443 patients with an average age of 48.2 years. Patients were divided into four BMI (body mass index) groups: normal (18.5-24.9), overweight (25-29.9), obese (30-39.9) and morbidly obese (=40).
"Greater BMI was associated with more advanced disease stage at presentation. Specifically, the obese and morbidly obese categories presented more as stage III or IV disease," according to the study results.
Researchers also note the obese and morbidly obese groups also presented with a higher prevalence of PTC tall cell variant, "suggesting that these groups have a higher risk of more aggressive tumor types."
"Given our findings, we believe that obese patients are at a higher risk of developing aggressive thyroid cancers and thus should be screened for thyroid cancer by sonography, which has been shown to be more sensitive in detecting thyroid cancer than physical examination alone," the authors conclude.
In an invited critique, Quan-Yang Duh, M.D., of the University of California, San Francisco, writes: "Harari and colleagues from UCLA (University of California, Los Angeles) showed us one more reason to be concerned about the current obesity epidemic - obese patients have more advanced thyroid cancer."
Duh continues: "This parallel increase in the rates of obesity and thyroid cancer is intriguing, but without a much larger population study, we cannot determine whether obesity causes thyroid cancer. However, the authors found that higher body mass index is associated with a later stage of thyroid cancer."
"For obese patients with papillary thyroid cancer, the bad news is that the cancer is likely to be more advanced. The good news is that thyroid operation remains safe even in obese patients with advanced disease," Duh concludes. thyroidcancer.livejournal.com/767.html
IAEA World Cancer Day Event at the Agency headquarters in Vienna, Austria. 3 February 2016.
Main Speakers:
Her Royal Highness Princess Dina Mired of Jordan
Her Excellency the First Lady of Belize Ms Kim Simplis Barrow
Mr Amadou Diarra of the International Federation of Pharmaceutical Manufacturers & Associations
Photo Credit: Dean Calma / IAEA
This morning a hummingbird appeared outside my window, hovered, and then disappeared. Wildlife rocks! It reminded me that at anytime something unexpected can happen that will brighten my day.
Excited for tomorrow, ready for the unexpected.
To recap: On Sunday, July 1st, I completed Cycle 45 Week 1. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
The OZ-08MMS Cancer was developed by the organization OZ as its second aquatic mobile suit. Despite being a mobile suit the Cancer lacked the basic humanoid appearance of other mobile suits and was designed without legs, strictly limiting its movement capabilities to aquatic environments such as the ocean. In place of legs the Cancer's primary propulsion systems were hydrojet engines built into the main body, while maneuvering was handled through ring of reversible side-spinning propeller blades on each arm.
The Cancer's primary weapons systems were four torpedo launchers in its arms. Those same arms mounted pincer-like claws with which the Cancer could grapple targets. Each claw contains two of the Cancer's four torpedo launchers.
A neighbor of ours recently found out that she has bladder cancer. I went to her house today to drop off some mail that accidentally got delivered to our house, and I noticed that their welcome sign was broken like this. It made me sad, reminding me of how heartbroken she and her family must have felt when they heard the bad news.
Before I went back home, I fixed their sign. Hopefully she can beat the cancer, and they'll be able to fix their heartbreak as well.
Con motivo de la celebración del Día Mundial del Cáncer 2013, el 1 de febrero se ha organizado un encuentro con las asociaciones que trabajan en este ámbito en Andalucía, para presentar un balance del Foro de Pacientes con Cáncer (www.onconocimiento.net/foro) puesto en marcha desde 2010 por el Plan Integral de Oncología de la Consejería de Salud y Bienestar Social, en colaboración con la Sociedad Andaluza de Cancerología.
eing a breast cancer patient is quite frightening. It’s like turning of the life upside down. Breast cancer care becomes the top priority of your life.
for complete info visit our breastlight blog
See Blogpost
(CC) Phillip Jeffrey. www.fadetoplay.com. Feel free to use this photo. I request that you link back to the original picture on Flickr and credit as shown above.
166/365
Camera: Canon XSi
Lens: 50mm f/1.4
Exp: ISO 800, f/5.6, 1/15
My cancer levels (45.8 igG from 35.7) have significantly spiked. On Tuesday, Sept 11, I had my specialist appointment and learned that I will need to begin a 4th cancer treatment (cancer drug + dextramethasone) if my levels increase again. My blood test rather than every 3 months will be monthly.
These will be tough days ahead for mentally and physically. I will focus on remaining positive.
There are everyday challenges living with multiple myeloma while on chemo. It would be easy for me to dwell endlessly on the tasks I’m no longer able to perform, the activities that I can no longer participate in, or the permanent changes to my body due to long-term treatment. However, I believe that type of negativity would make me sad, isolated, and feeling sorry for myself.
Instead, I emphasize positivity in my life. I focus on what I can do and count each day I get out of my bed as a success. I counter chemo side effects and symptoms of my disease (both known and unknown), with a belief that cancer will not bring me down. I do fun things that make me happy. I try to laugh each day.
I like to reward myself with mental gold stars each time I do something challenging such as navigating transit successfully to visit a friend, helping someone lost with directions, or coordinating my next specialist appointment. Emphasizing my successes helps me maintain a positive outlook on life. I’m all about moving forward, at a pace that is acceptable to me.
Cancer is what I have, it is not who I am.
To recap: On Sunday, March 4th, I completed Cycle 40 Week 4. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
World Cancer Day 2016 with "Support Cancer Care 4 All" at the IAEA headquarters in Vienna, Austria. 3 February 2016
Photo Credit: Dean Calma / IAEA
Used to have chemotherapy back in late 2008 to treat Stage IV Kidney Cancer.
This is the needle that went into my port-a-cath and then the drugs are the two back syringes.
La entrega de los galardones del I Certamen que fomenta la comunicación positiva en la prevención, detección y afrontamiento de la enfermedad del cáncer en Andalucía, ha tenido lugar el 3 de febrero de 2015 en el Hospital Virgen del Rocío de Sevilla, en el marco del II Encuentro del Foro de Pacientes con Cáncer.
Este encuentro fue organizado por la Consejería de Igualdad, Salud y Políticas Sociales y la Sociedad Andaluza de Cancerología, con motivo del Día Mundial del Cáncer 2015.
En la modalidad de Profesionales se ha premiado al proyecto ‘Una visión serena en el cáncer: relajación guiada y terapia integral’, desarrollado por el Servicio de Oncología Radioterápica del Complejo Hospitalario de Jaén.
Photo: Life is full of adventure that begin with the first step outside your home.
The results from my February monthly blood test were missing the m protein value. My particular type of multiple myeloma is less common and it is not always possible to get an m protein value - the best measure to determine my cancer levels. However, looking at less specific measures on my test results, I believe my cancer levels are similar to January (estimate between 13 and 14). The additional chemo seems to be keeping my cancer levels reasonably stable, however I remain hopeful for lower cancer levels for March.
M protein (g/L) (0 = no cancer detected)
Feb = value missing (estimate between 13 and 14)
Jan = 13 (began Ninlaro chemo - 2 weeks prior)
Dec = between 10 and 11
Nov = 8
July = 3.0 (ended dexamethasone - steroid)
Feb 2015 (began Pomalyst chemo + dexamethasone) = 36.1
Yes, everything takes longer than usual and I am quite forgetful, but each morning I wake up happy and ready for the day.
To recap: On Sunday, February 25th, I completed Cycle 40 Week 3. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.
Johnny raises awareness about prostate cancer to his step-father who has had issues with his prostate already. Read more athttp://bit.ly/qX9k5L.
Monday January 8th I began my 39th 4-week cycle and 153rd week of Pomalyst chemo. That day, I also started a new chemo called Ninlaro. In July I stopped taking dexamethasone, a steroid, due to eye damage. Pomalyst + dexamethasone had been more effective in keeping my cancer levels low and stable, so with only Pomalyst, my cancer levels have steadily risen. It is hoped that together these chemo (Ninlaro + Pomalyst) will provide a change in direction with minimal side effects.
Saturday morning, as a light rain fell, I travelled back to the Rose Garden at Queen Elizabeth Park to seek out some quiet and tranquility. Nature always helps keep me calm and stress-free, when facing unknowns (What if...? How will I...? Should I…?) in my everyday life.
Staying positive!
To recap: On Sunday, January 14th, I completed Cycle 39 Week 1. I have Multiple Myeloma and anemia, a rare cancer of the immune system. It is incurable, but treatable. Since February 9th 2015, I have been on Pomalyst and dexamethasone chemo treatment (Pom/dex). On July 16th, my dexamethasone treatment ended, due to eye damage, as reported by my Glaucoma Specialist, from long-term use. On January 9th I began Ninlaro chemo as my cancer levels have been steadily rising.